financetom
Business
financetom
/
Business
/
Update: Nvidia, Google Quantum AI to Advance Design of Next-Generation Quantum Computing Devices
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Nvidia, Google Quantum AI to Advance Design of Next-Generation Quantum Computing Devices
Nov 18, 2024 11:47 AM

02:20 PM EST, 11/18/2024 (MT Newswires) -- (Adds details in the fifth and sixth paragraphs.)

Nvidia ( NVDA ) said Monday it is working with Alphabet's (GOOG, GOOGL) Google Quantum AI to expedite the design of next-generation quantum computing devices.

The chipmaker said the Google Quantum AI team is utilizing a hybrid quantum-classical computing platform and Nvidia's ( NVDA ) Eos supercomputer to simulate the physics of its quantum processors, which will assist in overcoming quantum computing hardware's current limitations.

"The development of commercially useful quantum computers is only possible if we can scale up quantum hardware while keeping noise in check," said Guifre Vidal, research scientist from Google Quantum AI. "Using Nvidia ( NVDA ) accelerated computing, we're exploring the noise implications of increasingly larger quantum chip designs."

"Google's ( GOOG ) use of the CUDA-Q platform demonstrates the central role GPU-accelerated simulations have in advancing quantum computing to help solve real-world problems," said Tim Costa, director of quantum and HPC at Nvidia ( NVDA ).

The use of the CUDA-Q platform will help reduce the cost of such traditionally expensive simulations for Google ( GOOG ), and the noisy simulations will run in minutes instead a week, Nvidia ( NVDA ) said.

The software driving the simulations will be publicly available in the CUDA-Q platform, Nvidia ( NVDA ) said.

Shares of Nvidia ( NVDA ) fell 1.6% in recent Monday trading, and Alphabet rose 1.3%.

Price: 139.74, Change: -2.24, Percent Change: -1.58

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved